Periosteal hyperostosis resulting from prostaglandin therapy

Area of Science:

• Neonatal medicine
• Pediatric radiology
• Skeletal dysplasias

Background:

• Lamellated cortical hyperostosis in infants typically suggests trauma, congenital infection, or Caffey disease.
• Prostaglandin preparations are increasingly used for prolonged periods to manage congenital heart conditions by maintaining ductus arteriosus patency.

Observation:

• A case study or review focusing on premature infants treated with long-term prostaglandin infusions.
• Radiographic evidence of bilaterally symmetric, marked diaphyseal periosteal new bone formation.

Findings:

• Long-term administration of prostaglandin preparations can induce lamellated cortical hyperostosis.
• This induced hyperostosis may mimic other pathological conditions, necessitating careful clinical correlation.

Implications:

• Clinicians should consider prostaglandin-induced periosteal new bone formation in the differential diagnosis of hyperostosis in infants receiving these medications.
• This finding highlights a potential iatrogenic effect of prostaglandin therapy, requiring awareness for accurate diagnosis and management.
• Further research may be warranted to elucidate the precise mechanisms and long-term consequences of this drug-induced bone change.